Balram Chowbay

6.6k total citations · 1 hit paper
109 papers, 4.2k citations indexed

About

Balram Chowbay is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Balram Chowbay has authored 109 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 45 papers in Molecular Biology and 30 papers in Pharmacology. Recurrent topics in Balram Chowbay's work include Pharmacogenetics and Drug Metabolism (28 papers), Drug Transport and Resistance Mechanisms (25 papers) and Cancer therapeutics and mechanisms (19 papers). Balram Chowbay is often cited by papers focused on Pharmacogenetics and Drug Metabolism (28 papers), Drug Transport and Resistance Mechanisms (25 papers) and Cancer therapeutics and mechanisms (19 papers). Balram Chowbay collaborates with scholars based in Singapore, Australia and Japan. Balram Chowbay's co-authors include Shufeng Zhou, Junping Liu, Edmund J.D. Lee, Qingyu Zhou, Shu‐Feng Zhou, Lee Yong Lim, Suman Lal, Yin Bun Cheung, Wan‐Teck Lim and Peter Ang and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Balram Chowbay

108 papers receiving 4.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polymorphism of human cytochrome P450 enzymes and its clinical impact

2009 613 citations Shufeng Zhou, Balram Chowbay et al. Drug Metabolism Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Balram Chowbay Singapore	37	1.7k	1.4k	1.3k	611	514	109	4.2k
D. Kim Turgeon United States	32	1.4k 0.8×	1.1k 0.8×	895 0.7×	489 0.8×	442 0.9×	79	3.9k
Alan V. Boddy United Kingdom	41	2.2k 1.2×	2.4k 1.8×	620 0.5×	645 1.1×	670 1.3×	188	5.9k
Gillian Smith United Kingdom	44	1.5k 0.9×	2.1k 1.6×	1.1k 0.8×	331 0.5×	447 0.9×	127	7.1k
Timothy W. Synold United States	39	2.3k 1.3×	2.4k 1.8×	582 0.4×	555 0.9×	651 1.3×	194	5.9k
Andrew Rowland Australia	34	2.4k 1.4×	1.5k 1.1×	1.4k 1.0×	466 0.8×	732 1.4×	144	4.9k
Yijing He China	27	798 0.5×	724 0.5×	692 0.5×	617 1.0×	218 0.4×	138	2.9k
Shogo Ozawa Japan	42	2.1k 1.2×	2.1k 1.5×	1.6k 1.2×	763 1.2×	269 0.5×	177	5.3k
Toshiyuki Sakaeda Japan	45	2.8k 1.6×	2.1k 1.5×	974 0.7×	1.4k 2.3×	537 1.0×	220	7.1k
Reinhold Kerb Germany	42	3.3k 1.9×	1.8k 1.3×	1.6k 1.2×	1.8k 3.0×	351 0.7×	69	6.7k
Hannah M. Jones United States	36	1.3k 0.7×	1.1k 0.8×	1.4k 1.1×	524 0.9×	197 0.4×	105	3.8k

Countries citing papers authored by Balram Chowbay

Since Specialization

Citations

This map shows the geographic impact of Balram Chowbay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Balram Chowbay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Balram Chowbay more than expected).

Fields of papers citing papers by Balram Chowbay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Balram Chowbay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Balram Chowbay. The network helps show where Balram Chowbay may publish in the future.

Co-authorship network of co-authors of Balram Chowbay

This figure shows the co-authorship network connecting the top 25 collaborators of Balram Chowbay. A scholar is included among the top collaborators of Balram Chowbay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Balram Chowbay. Balram Chowbay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Xingjie, Xuecheng Sun, Auginia Natalia, et al.. (2024). Magnetic augmentation through multi-gradient coupling enables direct and programmable profiling of circulating biomarkers. Nature Communications. 15(1). 8410–8410. 5 indexed citations

Ghoshdastider, Umesh, Neha Rohatgi, Marjan Mojtabavi Naeini, et al.. (2021). Pan-Cancer Analysis of Ligand–Receptor Cross-talk in the Tumor Microenvironment. Cancer Research. 81(7). 1802–1812. 48 indexed citations

Pan, Sijun, Yan Zhang, Auginia Natalia, et al.. (2021). Extracellular vesicle drug occupancy enables real-time monitoring of targeted cancer therapy. Nature Nanotechnology. 16(6). 734–742. 87 indexed citations

Chen, Sylvia, et al.. (2021). Pharmacokinetics of oral versus intravenous ibuprofen for closure of patent ductus arteriosus: A pilot randomised controlled study. Journal of Paediatrics and Child Health. 58(3). 397–403. 4 indexed citations

Schroth, Werner, Thomas E. Mürdter, Robin Michelet, et al.. (2020). Obesity Alters Endoxifen Plasma Levels in Young Breast Cancer Patients: A Pharmacometric Simulation Approach. Clinical Pharmacology & Therapeutics. 108(3). 661–670. 21 indexed citations

Marvalim, Charlie, Wan‐Teck Lim, Ravindran Kanesvaran, et al.. (2017). Influence of the KDM4A rs586339 polymorphism on overall survival in Asian non-small-cell lung cancer patients. Pharmacogenetics and Genomics. 27(3). 120–123. 3 indexed citations

Chen, Sylvia, Khoon Lin Ling, Sai Wei Chuah, et al.. (2017). Predictive Role of NUDT15 Variants on Thiopurine-Induced Myelotoxicity in Asian Inflammatory Bowel Disease Patients. Pharmacogenomics. 19(1). 31–43. 27 indexed citations

Lal, Sunil K., London Lucien Ooi, Zee Wan Wong, et al.. (2016). Pharmacogenetics of ABCB5, ABCC5 and RLIP76 and doxorubicin pharmacokinetics in Asian breast cancer patients. The Pharmacogenomics Journal. 17(4). 337–343. 20 indexed citations

Chen, Sylvia, et al.. (2016). Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review. Drug Metabolism Reviews. 48(4). 502–540. 19 indexed citations

10.

Tan, Eng Huat, Daniel S.W. Tan, Benjamin Haaland, et al.. (2015). Metronomic vinorelbine (oral) in combination with sorafenib in advanced non-small cell lung cancer. Lung Cancer. 88(3). 289–296. 17 indexed citations

11.

Singh, Onkar, et al.. (2012). SLC22A1-ABCB1 Haplotype Profiles Predict Imatinib Pharmacokinetics in Asian Patients with Chronic Myeloid Leukemia. PLoS ONE. 7(12). e51771–e51771. 46 indexed citations

12.

Singh, Onkar, et al.. (2011). The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients. Cancer Chemotherapy and Pharmacology. 67(6). 1471–1478. 56 indexed citations

13.

Chowbay, Balram, et al.. (2011). ITRAQ-Coupled 2-D LC-MS/MS Analysis of Differentially Expressed Serum Proteins in Nasopharyngeal Carcinoma Clinical Samples: Potential in Biomarker Discovery. Journal of Medical Imaging and Health Informatics. 1(2). 177–183. 3 indexed citations

14.

Bai, Jing, et al.. (2010). A comparative proteomic analysis of HepG2 cells incubated by S(−) and R(+) enantiomers of anti‐coagulating drug warfarin. PROTEOMICS. 10(7). 1463–1473. 5 indexed citations

15.

Chowbay, Balram, Brian C. Goh, Srinivasa Rao Jada, et al.. (2008). Influence of UGT1A9 intronic I399C4T polymorphism on SN-38 glucuronidation in Asian cancer patients. Faculty of Health; Institute of Health and Biomedical Innovation. 2 indexed citations

16.

Lal, Suman, Zee Wan Wong, Edwin Sandanaraj, et al.. (2008). Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients. Cancer Science. 99(4). 816–823. 113 indexed citations

17.

Yu, Xi-Yong, Lin Shu-guang, Zhi-Wei Zhou, et al.. (2007). Role of P-Glycoprotein in the Intestinal Absorption of Tanshinone IIA, a Major Active Ingredient in the Root of Salvia miltiorrhiza Bunge. Current Drug Metabolism. 8(4). 325–340. 61 indexed citations

18.

Jada, Srinivasa Rao, Robert C. Lim, Xiaochen Shu, et al.. (2007). Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan‐induced neutropenia in Asian cancer patients. Cancer Science. 98(9). 1461–1467. 96 indexed citations

19.

Yu, Xi-Yong, Lin Shu-guang, Xiaohong Chen, et al.. (2007). Transport of Cryptotanshinone, a Major Active Triterpenoid in Salvia Miltiorrhiza Bunge Widely Used in the Treatment of Stroke and Alzheimers Disease, Across the Blood-Brain Barrier. Current Drug Metabolism. 8(4). 365–377. 75 indexed citations

20.

Zhou, Qingyu, et al.. (2005). Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models. Cancer Chemotherapy and Pharmacology. 56(6). 569–577. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact